Essilor acquires J&J ophthalmic lens business

Dallas—Essilor will acquire Johnson & Johnson Vision Care Inc.'s Spectacle Lens Group, including the group's Definity brand of progressive lenses.

Related Videos
J. Peter Campbell, MD, MPH
Expanding accessibility of vision correction with spectacles for children with cranial abnormalities
Elkin: Talking about the importance of pediatric eye health and safety
Identifying 3 barriers keeping families from accessing cataract treatment for their children in India
Edward Manche, MD
Related Content

Factors in increasing prevalence rates of myopia identified in China

May 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Ocular injuries in children caused by toys on the rise

May 14th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

Researchers zero in on protecting the vision of premature babies

May 8th 2023

The revolving paradigm of ROP treatment

May 3rd 2023

Factors in increasing prevalence rates of myopia identified in China

May 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Ocular injuries in children caused by toys on the rise

May 14th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

Researchers zero in on protecting the vision of premature babies

May 8th 2023

The revolving paradigm of ROP treatment

May 3rd 2023

Factors in increasing prevalence rates of myopia identified in China

May 24th 2023

ROP: Treating and preventing blindness in preterm babies

October 18th 2021

Ocular injuries in children caused by toys on the rise

May 14th 2023

Managing a changing landscape of IRD pediatric cases

May 10th 2021

Researchers zero in on protecting the vision of premature babies

May 8th 2023

The revolving paradigm of ROP treatment

May 3rd 2023
© 2023 MJH Life Sciences

All rights reserved.